Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience

BACKGROUND: The efficacy and safety of the lapatinib and capecitabine combination remain elusive in elderly patients with metastatic breast cancer (MBC), who progress after trastuzumab-based therapy. PATIENTS AND METHODS: A total of 26 patients with HER2-positive MBC were included in this retrospect...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Cetin, Bulent, Benekli, Mustafa, Dane, Faysal, Boruban, Cem, Gumus, Mahmut, Oksuzoglu, Berna, Kaplan, Mehmet A., Tufan, Gulnihal, Sevinc, Alper, Coskun, Ugur, Buyukberber, Suleyman
פורמט: Artigo
שפה:Inglês
יצא לאור: S. Karger GmbH 2013
נושאים:
Original Article · Originalarbeit
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971792/
https://ncbi.nlm.nih.gov/pubmed/24715846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000346829
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים